Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes

BACKGROUND: Development of a standardized platform for the rapid expansion of tumor-infiltrating lymphocytes (TILs) with anti-tumor function from patients with limited TIL numbers or tumor tissues challenges their clinical application. METHODS: To facilitate adoptive immunotherapy, we applied geneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qunrui, Loisiou, Maria, Levine, Bruce L, Suhoski, Megan M, Riley, James L, June, Carl H, Coukos, George, Powell, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162913/
https://www.ncbi.nlm.nih.gov/pubmed/21827675
http://dx.doi.org/10.1186/1479-5876-9-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162913/
https://www.ncbi.nlm.nih.gov/pubmed/21827675
http://dx.doi.org/10.1186/1479-5876-9-131

Ejemplares similares